These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cyclic AMP, but not basic FGF, increases the in vitro survival of mesencephalic dopaminergic neurons and protects them from MPP(+)-induced degeneration. Hartikka J, Staufenbiel M, Lübbert H. J Neurosci Res; 1992 Jun; 32(2):190-201. PubMed ID: 1357186 [Abstract] [Full Text] [Related]
8. FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice. Zechel S, Jarosik J, Kiprianova I, Schober A, Unsicker K, von Bohlen und Halbach O. Eur J Neurosci; 2006 Mar; 23(6):1671-5. PubMed ID: 16553632 [Abstract] [Full Text] [Related]
11. Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures. Friedman LK, Mytilineou C. J Pharmacol Exp Ther; 1990 May; 253(2):892-8. PubMed ID: 2338661 [Abstract] [Full Text] [Related]
19. Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons. Reiriz J, Espejo M, Ventura F, Ambrosio S, Alberch J. J Neurobiol; 1999 Feb 05; 38(2):161-70. PubMed ID: 10022564 [Abstract] [Full Text] [Related]
20. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine. Luellen BA, Miller DB, Chisnell AC, Murphy DL, O'Callaghan JP, Andrews AM. J Pharmacol Exp Ther; 2003 Dec 05; 307(3):923-31. PubMed ID: 14561848 [Abstract] [Full Text] [Related] Page: [Next] [New Search]